Drugs / Wumeiwan Jiawei Fang
Wumeiwan Jiawei Fang
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05618470 | Jan 2018 → Aug 2024 | benign essential blepharospasm, blepharospasm-oromandibular dystonia syndrome, dry eye syndrome | China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wumeiwan Jiawei Fang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05618470 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Wu Mei Wan is a traditional Chinese medicine prescription” NCT05618470 ↗ |
| Route | Oral | “orally administered Wumeiwan Jiawei Fang prescription granules” NCT05618470 ↗ |